Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction.
Sheng-Yu LiLei LiuDing-Kun WangXiao-Song DingWei-Ping LiHong-Wei LiPublished in: Journal of inflammation research (2023)
The higher increase of PTX3 level 24-hour after pPCI appeared to have a potential value in independently predicting the incidence of 1-year MACCEs in STEMI patients, especially for coronary revascularization.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- coronary artery disease
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- acute coronary syndrome
- antiplatelet therapy
- end stage renal disease
- newly diagnosed
- coronary artery bypass
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- heart failure
- prognostic factors
- risk factors
- coronary artery
- blood pressure
- patient reported outcomes
- patient reported